1. Home
  2. SNCR vs ALVR Comparison

SNCR vs ALVR Comparison

Compare SNCR & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • ALVR
  • Stock Information
  • Founded
  • SNCR 2000
  • ALVR 2013
  • Country
  • SNCR United States
  • ALVR United States
  • Employees
  • SNCR N/A
  • ALVR N/A
  • Industry
  • SNCR EDP Services
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SNCR Technology
  • ALVR Health Care
  • Exchange
  • SNCR Nasdaq
  • ALVR Nasdaq
  • Market Cap
  • SNCR 137.5M
  • ALVR 87.7M
  • IPO Year
  • SNCR 2006
  • ALVR 2020
  • Fundamental
  • Price
  • SNCR $11.25
  • ALVR $0.90
  • Analyst Decision
  • SNCR
  • ALVR Sell
  • Analyst Count
  • SNCR 0
  • ALVR 5
  • Target Price
  • SNCR N/A
  • ALVR $1.00
  • AVG Volume (30 Days)
  • SNCR 81.2K
  • ALVR 155.6K
  • Earning Date
  • SNCR 11-12-2024
  • ALVR 11-04-2024
  • Dividend Yield
  • SNCR N/A
  • ALVR N/A
  • EPS Growth
  • SNCR N/A
  • ALVR N/A
  • EPS
  • SNCR N/A
  • ALVR N/A
  • Revenue
  • SNCR $167,615,000.00
  • ALVR N/A
  • Revenue This Year
  • SNCR $7.76
  • ALVR N/A
  • Revenue Next Year
  • SNCR $5.83
  • ALVR N/A
  • P/E Ratio
  • SNCR N/A
  • ALVR N/A
  • Revenue Growth
  • SNCR 33.39
  • ALVR N/A
  • 52 Week Low
  • SNCR $2.70
  • ALVR $0.58
  • 52 Week High
  • SNCR $15.46
  • ALVR $2.49
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 43.11
  • ALVR 69.10
  • Support Level
  • SNCR $10.45
  • ALVR $0.74
  • Resistance Level
  • SNCR $11.44
  • ALVR $0.91
  • Average True Range (ATR)
  • SNCR 0.57
  • ALVR 0.06
  • MACD
  • SNCR -0.06
  • ALVR 0.01
  • Stochastic Oscillator
  • SNCR 31.58
  • ALVR 94.50

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

Share on Social Networks: